WHO Pleads for Support Amid Major Ebola Outbreak in Congo as Vaccine Trials Progress

The World Health Organization is appealing for more support to tackle the largest-ever Ebola outbreak in the Democratic Republic of Congo, which comes as Moderna has initiated its first Phase 1 clinical trial for an experimental mRNA vaccine targeting the Ebola variant responsible for the major outbreak.

4 Aug, 15:00 — 5 Aug, 01:58

Post Share

Why this matters

The ongoing Ebola outbreak in the Democratic Republic of Congo poses a significant public health threat, with high fatality rates. The development of new vaccine candidates, especially mRNA technology, is crucial for controlling the current outbreak and preventing future epidemics, offering hope for a more effective response.

Key entitiesModerna Inc.Health Canada Democratic Republic of Congo

The Story

What 6 sources agree on, dispute, and miss

What sources agree on

Moderna has received authorization to begin Phase 1 trials for an experimental Ebola vaccine.
The vaccine is an mRNA type.
The trials are in response to an ongoing Ebola outbreak in the Democratic Republic of Congo.
This is Moderna's second Ebola vaccine candidate to enter clinical trials for the current strain.

Key claims3 agreed · 1 unverified

✓

Moderna's Ebola vaccine trial has received a 'green light'.

agreed·politikencbcbloomberg

✓

Health Canada authorized the mRNA vaccine trial.

agreed·cbcbloomberg

✓

The trial is a Phase 1 study.

agreed·bloombergcbc

The Ebola outbreak in Congo is the deadliest.

unverified·bloomberg

The Story

Analyzing sources…

Source Diversity

High (67/100)

6 sources33/33

Spectrum spread— 3/5 buckets covered17/33

Far L

Left4

Left (4)

japan-timesdr-dkpolitikencbc

Center1

Center (1)

bloomberg

Right1

Right (1)

berlingske

Far R

Geographic diversity— 4 regions17/34

Denmark3Japan1Canada1US1

Political spectrum

LeftCenterRight

politiken

cbc

bloomberg

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

politikencenter-leftcenter-leftneutralMostly FactualFactual reporting on health development

cbccenter-leftcenter-leftneutralHighFocus on public health and Canadian authorization

Coverage leans: center-left

The coverage is largely factual and focused on the scientific and public health aspects of the vaccine trial, with a slight lean towards emphasizing the urgency of the health crisis.

Sources

Showing 3 of 6 sources

bloombergHigh22d ago

Moderna Starts Phase 1 Trial of Experimental Ebola Vaccine for Congo Outbreak

Moderna Inc. has begun testing an experimental Ebola vaccine in people, marking the second candidate to enter clinical trials against the strain driving the deadliest Ebola outbreak in Democratic Republic of Congo’s history.

By Jason Gale

Read full article →

cbcHigh22d ago

Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo

<img src='https://i.cbc.ca/ais/f8ec74e7-865d-4cb2-93a1-86e14dbcfdd9,1785855744692/full/max/0/default.jpg?im=Crop%2Crect%3D%280%2C192%2C4499%2C2530%29%3BResize%3D%28620%29' alt='Congolese children read a poster' width='620' height='349' title='FILE PHOTO: Congolese children Ibrah Asimwe and Alex Uketi read an advocacy poster as aid agencies intensify efforts to contain a new Ebola outbreak involving the Bundibugyo strain outbreak, in Bunia, Ituri province, Democratic Republic of Congo, May 20,...

Read full article →

japan-timesMostly Factual22d ago